← Eichor
Study identifier: NCT06278844 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDication

Condition: Heart Failure With Reduced Ejection Fraction · Heart Failure With Preserved Ejection Fraction · Heart Conduction Disorder  ·  Sponsor: University Hospital, Antwerp

PhaseNA
Planned participants75
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This randomized controlled trial aims to investigate the impact of conduction system pacing in comparison to right ventricular apical pacing on exercise capacity, as measured by peak oxygen uptake (VO2peak), in heart failure patients with indication for pacing but no compelling indication for cardiac resynchronization therapy (CRT). The mechanisms of exercise intolerance in heart failure patients influenced by conduction system pacing will be assessed.

This description comes directly from the study's public registry record.

Talk to the study team

Andreas Gevaert  ·  038213538  ·  Andreas.gevaert@uza.be

Faro Verelst  ·  038213538  ·  Faro.verelst@uza.be

Always discuss trial participation with your own doctor first.

Locations (1)

Universitair Ziekenhuis AntwerpenEdegem, Antwerp, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06278844